Platelet signaling: a complex interplay between inhibitory and activatory networks

Journal of Thrombosis and Haemostasis - Tập 14 - Trang 918-930 - 2016
A.P. Bye1, A.J. Unsworth1, J.M. Gibbins1
1Institute of Cardiovascular and Metabolic Research, School of Biological Sciences, University of Reading, Reading, UK

Tài liệu tham khảo

Aarts, 1988, Blood platelets are concentrated near the wall and red blood cells, in the center in flowing blood, Arteriosclerosis, 8, 819, 10.1161/01.ATV.8.6.819 Smolenski, 2012, Novel roles of cAMP/cGMP‐dependent signaling in platelets, J Thromb Haemost, 10, 167, 10.1111/j.1538-7836.2011.04576.x Mellion, 1981, Evidence for the inhibitory role of guanosine 3′,5′‐monophosphate in ADP‐induced human platelet aggregation in the presence of nitric oxide and related vasodilators, Blood, 57, 946, 10.1182/blood.V57.5.946.946 Dutta‐Roy, 1987, Purification and properties of prostaglandin E1/prostacyclin receptor of human blood platelets, J Biol Chem, 262, 12685, 10.1016/S0021-9258(18)45261-1 Gorman, 1977, Modulation of human platelet adenylate cyclase by prostacyclin (PGX), Prostaglandins, 13, 377, 10.1016/0090-6980(77)90018-1 Altschuler, 1993, Mutational analysis of the cAMP‐dependent protein kinase‐mediated phosphorylation site of Rap1b, J Biol Chem, 268, 7527, 10.1016/S0021-9258(18)53207-5 Tertyshnikova, 1998, cGMP inhibits IP3‐induced Ca2+ release in intact rat megakaryocytes via cGMP‐ and cAMP‐dependent protein kinases, J Physiol, 512, 89, 10.1111/j.1469-7793.1998.089bf.x Eigenthaler, 1993, Defective nitrovasodilator‐stimulated protein phosphorylation and calcium regulation in cGMP‐dependent protein kinase‐deficient human platelets of chronic myelocytic leukemia, J Biol Chem, 268, 13526, 10.1016/S0021-9258(19)38681-8 Massberg, 1999, Increased adhesion and aggregation of platelets lacking cyclic guanosine 3′,5′‐monophosphate kinase I, J Exp Med, 189, 1255, 10.1084/jem.189.8.1255 Cheng, 2002, Role of prostacyclin in the cardiovascular response to thromboxane A2, Science, 296, 539, 10.1126/science.1068711 Kobayashi, 2004, Roles of thromboxane A(2) and prostacyclin in the development of atherosclerosis in apoE‐deficient mice, J Clin Invest, 114, 784, 10.1172/JCI200421446 Marcus, 1997, The endothelial cell ecto‐ADPase responsible for inhibition of platelet function is CD39, J Clin Invest, 99, 1351, 10.1172/JCI119294 Johnston‐Cox, 2011, Adenosine and blood platelets, Purinergic Signalling, 7, 357, 10.1007/s11302-011-9220-4 Naik, 2014, Junctional adhesion molecule‐A suppresses platelet integrin alphaIIbbeta3 signaling by recruiting Csk to the integrin–c‐Src complex, Blood, 123, 1393, 10.1182/blood-2013-04-496232 Naik, 2012, JAM‐A protects from thrombosis by suppressing integrin alphaIIbbeta3‐dependent outside‐in signaling in platelets, Blood, 119, 3352, 10.1182/blood-2011-12-397398 Gibbins, 2004, Platelet adhesion signalling and the regulation of thrombus formation, J Cell Sci, 117, 3415, 10.1242/jcs.01325 Heemskerk, 2002, Platelet activation and blood coagulation, Thromb Haemost, 88, 186, 10.1055/s-0037-1613209 Watson, 2005, GPVI and integrin alphaIIb beta3 signaling in platelets, J Thromb Haemost, 3, 1752, 10.1111/j.1538-7836.2005.01429.x Harper, 2010, Diverse functions of protein kinase C isoforms in platelet activation and thrombus formation, J Thromb Haemost, 8, 454, 10.1111/j.1538-7836.2009.03722.x Offermanns, 2006, Activation of platelet function through G protein‐coupled receptors, Circ Res, 99, 1293, 10.1161/01.RES.0000251742.71301.16 Born, 1972, The functional physiology of blood platelets, Adv Exp Med Biol, 34, 3, 10.1007/978-1-4684-3231-2_1 Yang, 1996, Human platelet signaling defect characterized by impaired production of inositol‐1,4,5‐triphosphate and phosphatidic acid and diminished Pleckstrin phosphorylation: evidence for defective phospholipase C activation, Blood, 88, 1676, 10.1182/blood.V88.5.1676.1676 Moroi, 2015, Impact of the PI3‐kinase/Akt pathway on ITAM and hemITAM receptors: haemostasis, platelet activation and antithrombotic therapy, Biochem Pharmacol, 94, 186, 10.1016/j.bcp.2015.02.004 Spalton, 2009, The novel Syk inhibitor R406 reveals mechanistic differences in the initiation of GPVI and CLEC‐2 signaling in platelets, J Thromb Haemost, 7, 1192, 10.1111/j.1538-7836.2009.03451.x Atkinson, 2003, Tec regulates platelet activation by GPVI in the absence of Btk, Blood, 102, 3592, 10.1182/blood-2003-04-1142 Bye, 2015, Ibrutinib inhibits platelet integrin alphaIIbbeta3 outside‐in signaling and thrombus stability but not adhesion to collagen, Arterioscler Thromb Vasc Biol, 35, 2326, 10.1161/ATVBAHA.115.306130 Judd, 2001, The role of the adapter molecule SLP‐76 in platelet function, Oncogene, 20, 6291, 10.1038/sj.onc.1204772 Wonerow, 2002, Differential role of glycolipid‐enriched membrane domains in glycoprotein VI‐ and integrin‐mediated phospholipase Cgamma2 regulation in platelets, Biochem J, 364, 755, 10.1042/bj20020128 Nonne, 2005, Importance of platelet phospholipase Cgamma2 signaling in arterial thrombosis as a function of lesion severity, Arterioscler Thromb Vasc Biol, 25, 1293, 10.1161/01.ATV.0000163184.02484.69 Mundell, 2006, Distinct roles for protein kinase C isoforms in regulating platelet purinergic receptor function, Mol Pharmacol, 70, 1132, 10.1124/mol.106.023549 Strehl, 2007, Dual role of platelet protein kinase C in thrombus formation: stimulation of pro‐aggregatory and suppression of procoagulant activity in platelets, J Biol Chem, 282, 7046, 10.1074/jbc.M611367200 Unsworth, 2011, Submaximal inhibition of protein kinase C restores ADP‐induced dense granule secretion in platelets in the presence of Ca2+, J Biol Chem, 286, 21073, 10.1074/jbc.M110.187138 Poole, 2004, PKC‐interacting proteins: from function to pharmacology, Trends Pharmacol Sci, 25, 528, 10.1016/j.tips.2004.08.006 O'Brien, 2011, An important role for Akt3 in platelet activation and thrombosis, Blood, 118, 4215, 10.1182/blood-2010-12-323204 Moore, 2013, Dual regulation of glycogen synthase kinase 3 (GSK3)alpha/beta by protein kinase C (PKC)alpha and Akt promotes thrombin‐mediated integrin alphaIIbbeta3 activation and granule secretion in platelets, J Biol Chem, 288, 3918, 10.1074/jbc.M112.429936 Toth‐Zsamboki, 2003, P2X1‐mediated ERK2 activation amplifies the collagen‐induced platelet secretion by enhancing myosin light chain kinase activation, J Biol Chem, 278, 46661, 10.1074/jbc.M308452200 Flevaris, 2009, Two distinct roles of mitogen‐activated protein kinases in platelets and a novel Rac1‐MAPK‐dependent integrin outside‐in retractile signaling pathway, Blood, 113, 893, 10.1182/blood-2008-05-155978 Bobe, 2001, Phosphatidylinositol 3‐kinase‐dependent translocation of phospholipase Cgamma2 in mouse megakaryocytes is independent of Bruton tyrosine kinase translocation, Blood, 97, 678, 10.1182/blood.V97.3.678 Guidetti, 2015, PI3K/Akt in platelet integrin signaling and implications in thrombosis, Adv Biol Regul, 59, 36, 10.1016/j.jbior.2015.06.001 Gilio, 2009, Non‐redundant roles of phosphoinositide 3‐kinase isoforms alpha and beta in glycoprotein VI‐induced platelet signaling and thrombus formation, J Biol Chem, 284, 33750, 10.1074/jbc.M109.048439 Kim, 2009, Role of phosphoinositide 3‐kinase beta in glycoprotein VI‐mediated Akt activation in platelets, J Biol Chem, 284, 33763, 10.1074/jbc.M109.048553 Hartwig, 2013, The platelet cytoskeleton, 145 Janmey, 1994, Phosphoinositides and calcium as regulators of cellular actin assembly and disassembly, Annu Rev Physiol, 56, 169, 10.1146/annurev.ph.56.030194.001125 Adelstein, 1975, The interaction of platelet actin, myosin and myosin light chain kinase, Ciba Found Symp, 35, 101 Machesky, 1999, Signaling to actin dynamics, J Cell Biol, 146, 267, 10.1083/jcb.146.2.267 Aslan, 2013, Rho GTPases in platelet function, J Thromb Haemost, 11, 35, 10.1111/jth.12051 Wentworth, 2006, Vasodilator‐stimulated phosphoprotein (VASP) is phosphorylated on Ser157 by protein kinase C‐dependent and ‐independent mechanisms in thrombin‐stimulated human platelets, Biochem J, 393, 555, 10.1042/BJ20050796 Polgar, 2002, Vesicle‐associated membrane protein 3 (VAMP‐3) and VAMP‐8 are present in human platelets and are required for granule secretion, Blood, 100, 1081, 10.1182/blood.V100.3.1081 Ren, 2010, Munc13‐4 is a limiting factor in the pathway required for platelet granule release and hemostasis, Blood, 116, 869, 10.1182/blood-2010-02-270934 Nishikawa, 1980, Ca2+‐calmodulin‐dependent phosphorylation and platelet secretion, Nature, 287, 863, 10.1038/287863a0 Quetglas, 2002, Calmodulin and lipid binding to synaptobrevin regulates calcium‐dependent exocytosis, EMBO J, 21, 3970, 10.1093/emboj/cdf404 Neumuller, 2009, Synaptotagmin‐like protein 1 interacts with the GTPase‐activating protein Rap1GAP2 and regulates dense granule secretion in platelets, Blood, 114, 1396, 10.1182/blood-2008-05-155234 Rink, 1983, Diacylglycerol and phorbol ester stimulate secretion without raising cytoplasmic free calcium in human platelets, Nature, 305, 317, 10.1038/305317a0 Chung, 2000, Protein kinase C phosphorylation of syntaxin 4 in thrombin‐activated human platelets, J Biol Chem, 275, 25286, 10.1074/jbc.M004204200 Reed, 1999, Human platelets contain SNARE proteins and a Sec1p homologue that interacts with syntaxin 4 and is phosphorylated after thrombin activation: implications for platelet secretion, Blood, 93, 2617, 10.1182/blood.V93.8.2617 Schraw, 2003, A role for Sec1/Munc18 proteins in platelet exocytosis, Biochem J, 374, 207, 10.1042/bj20030610 Stefanini, 2012, Rap1–Rac1 circuits potentiate platelet activation, Arterioscler Thromb Vasc Biol, 32, 434, 10.1161/ATVBAHA.111.239194 Borsch‐Haubold, 1997, Phosphorylation and activation of cytosolic phospholipase A2 by 38‐kDa mitogen‐activated protein kinase in collagen‐stimulated human platelets, Eur J Biochem, 245, 751, 10.1111/j.1432-1033.1997.t01-1-00751.x Garcia, 2007, Regulation and functional consequences of ADP receptor‐mediated ERK2 activation in platelets, Biochem J, 404, 299, 10.1042/BJ20061584 Garcia, 2010, Role of phosphoinositide 3‐kinase beta in platelet aggregation and thromboxane A2 generation mediated by Gi signalling pathways, Biochem J, 429, 369, 10.1042/BJ20100166 Taylor, 2014, Amplification of human platelet activation by surface pannexin‐1 channels, J Thromb Haemost, 12, 987, 10.1111/jth.12566 Tadokoro, 2003, Talin binding to integrin beta tails: a final common step in integrin activation, Science, 302, 103, 10.1126/science.1086652 Moser, 2008, Kindlin‐3 is essential for integrin activation and platelet aggregation, Nat Med, 14, 325, 10.1038/nm1722 Chrzanowska‐Wodnicka, 2005, Rap1b is required for normal platelet function and hemostasis in mice, J Clin Invest, 115, 680, 10.1172/JCI22973 Stefanini, 2009, CalDAG‐GEFI is at the nexus of calcium‐dependent platelet activation, Blood, 114, 2506, 10.1182/blood-2009-04-218768 Kawasaki, 1998, A Rap guanine nucleotide exchange factor enriched highly in the basal ganglia, Proc Natl Acad Sci USA, 95, 13278, 10.1073/pnas.95.22.13278 Woulfe, 2002, Activation of Rap1B by G(i) family members in platelets, J Biol Chem, 277, 23382, 10.1074/jbc.M202212200 Stefanini, 2015, RASA3 is a critical inhibitor of RAP1‐dependent platelet activation, J Clin Invest, 125, 1419, 10.1172/JCI77993 Han, 2006, Reconstructing and deconstructing agonist‐induced activation of integrin alphaIIbbeta3, Curr Biol, 16, 1796, 10.1016/j.cub.2006.08.035 Stritt, 2015, Rap1‐GTP‐interacting adaptor molecule (RIAM) is dispensable for platelet integrin activation and function in mice, Blood, 125, 219, 10.1182/blood-2014-08-597542 Poulter, 2015, Platelet actin nodules are podosome‐like structures dependent on Wiskott–Aldrich syndrome protein and ARP2/3 complex, Nat Commun, 6, 7254, 10.1038/ncomms8254 Jones, 2012, Endogenous inhibitory mechanisms and the regulation of platelet function, Methods Mol Biol, 788, 341, 10.1007/978-1-61779-307-3_23 Senis, 2013, Protein‐tyrosine phosphatases: a new frontier in platelet signal transduction, J Thromb Haemost, 11, 1800, 10.1111/jth.12359 Hardy, 2005, P2Y1 and P2Y12 receptors for ADP desensitize by distinct kinase‐dependent mechanisms, Blood, 105, 3552, 10.1182/blood-2004-07-2893 Cicmil, 2002, Platelet endothelial cell adhesion molecule‐1 signaling inhibits the activation of human platelets, Blood, 99, 137, 10.1182/blood.V99.1.137 Jones, 2009, PECAM‐1 expression and activity negatively regulate multiple platelet signaling pathways, FEBS Lett, 583, 3618, 10.1016/j.febslet.2009.10.037 Wong, 2009, CEACAM1 negatively regulates platelet–collagen interactions and thrombus growth in vitro and in vivo, Blood, 113, 1818, 10.1182/blood-2008-06-165043 Alshahrani, 2014, CEACAM2 negatively regulates hemi (ITAM‐bearing) GPVI and CLEC‐2 pathways and thrombus growth in vitro and in vivo, Blood, 124, 2431, 10.1182/blood-2014-04-569707 Newland, 2007, The novel inhibitory receptor G6B is expressed on the surface of platelets and attenuates platelet function in vitro, Blood, 109, 4806, 10.1182/blood-2006-09-047449 Mori, 2008, G6b‐B inhibits constitutive and agonist‐induced signaling by glycoprotein VI and CLEC‐2, J Biol Chem, 283, 35419, 10.1074/jbc.M806895200 Fan, 2014, Paired immunoglobulin‐like receptor B regulates platelet activation, Blood, 124, 2421, 10.1182/blood-2014-03-557645 Sun, 1996, Individually distinct Ig homology domains in PECAM‐1 regulate homophilic binding and modulate receptor affinity, J Biol Chem, 271, 11090, 10.1074/jbc.271.19.11090 Kharitonenkov, 1997, A family of proteins that inhibit signalling through tyrosine kinase receptors, Nature, 386, 181, 10.1038/386181a0 Bruhns, 2000, Molecular basis of the recruitment of the SH2 domain‐containing inositol 5‐phosphatases SHIP1 and SHIP2 by fcgamma RIIB, J Biol Chem, 275, 37357, 10.1074/jbc.M003518200 Moraes, 2010, Platelet endothelial cell adhesion molecule‐1 regulates collagen‐stimulated platelet function by modulating the association of phosphatidylinositol 3‐kinase with Grb‐2‐associated binding protein‐1 and linker for activation of T cells, J Thromb Haemost, 8, 2530, 10.1111/j.1538-7836.2010.04025.x Jones, 2012, Regulation of platelet biology by platelet endothelial cell adhesion molecule‐1, Platelets, 23, 331, 10.3109/09537104.2011.626091 Falati, 2006, Platelet PECAM‐1 inhibits thrombus formation in vivo, Blood, 107, 535, 10.1182/blood-2005-04-1512 Wee, 2005, The Ig‐ITIM superfamily member PECAM‐1 regulates the ‘outside‐in’ signaling properties of integrin alpha(IIb)beta3 in platelets, Blood, 106, 3816, 10.1182/blood-2005-03-0911 Yip, 2015, CEACAM1 regulates integrin alphaIIbbeta3‐mediated functions in platelets, Platelets, 27, 1 Nasdala, 2002, A transmembrane tight junction protein selectively expressed on endothelial cells and platelets, J Biol Chem, 277, 16294, 10.1074/jbc.M111999200 Stalker, 2009, Endothelial cell specific adhesion molecule (ESAM) localizes to platelet–platelet contacts and regulates thrombus formation in vivo, J Thromb Haemost, 7, 1886, 10.1111/j.1538-7836.2009.03606.x Kashiwagi, 2005, Negative regulation of platelet function by a secreted cell repulsive protein, semaphorin 3A, Blood, 106, 913, 10.1182/blood-2004-10-4092 Serini, 2003, Class 3 semaphorins control vascular morphogenesis by inhibiting integrin function, Nature, 424, 391, 10.1038/nature01784 Steele, 2009, Canonical Wnt signaling negatively regulates platelet function, Proc Natl Acad Sci USA, 106, 19836, 10.1073/pnas.0906268106 Steele, 2012, WNT‐3a modulates platelet function by regulating small GTPase activity, FEBS Lett, 586, 2267, 10.1016/j.febslet.2012.05.060 Moraes, 2010, Non‐genomic effects of PPARgamma ligands: inhibition of GPVI‐stimulated platelet activation, J Thromb Haemost, 8, 577, 10.1111/j.1538-7836.2009.03732.x Moraes, 2007, Nongenomic signaling of the retinoid X receptor through binding and inhibiting Gq in human platelets, Blood, 109, 3741, 10.1182/blood-2006-05-022566 Spyridon, 2011, LXR as a novel antithrombotic target, Blood, 117, 5751, 10.1182/blood-2010-09-306142 Moraes, 2005, Ligand‐specific glucocorticoid receptor activation in human platelets, Blood, 106, 4167, 10.1182/blood-2005-04-1723 Ali, 2006, Role of nuclear receptor signaling in platelets: antithrombotic effects of PPARbeta, FASEB J, 20, 326, 10.1096/fj.05-4395fje Lee, 2003, Transcriptional repression of atherogenic inflammation: modulation by PPARdelta, Science, 302, 453, 10.1126/science.1087344 Ali, 2009, Antiplatelet actions of statins and fibrates are mediated by PPARs, Arterioscler Thromb Vasc Biol, 29, 706, 10.1161/ATVBAHA.108.183160 Ali, 2009, PPARβ/δ agonists modulate platelet function via a mechanism involving PPAR receptors and specific association/repression of PKCα – Brief Report, Arterioscler Thromb Vasc Biol, 29, 1871, 10.1161/ATVBAHA.109.193367 Dunster, 2015, Regulation of early steps of GPVI signal transduction by phosphatases: a systems biology approach, PLoS Comput Biol, 11, e1004589, 10.1371/journal.pcbi.1004589 Laurent, 2014, Class I PI 3‐kinases signaling in platelet activation and thrombosis: PDK1/Akt/GSK3 axis and impact of PTEN and SHIP1, Adv Biol Regul, 54, 162, 10.1016/j.jbior.2013.09.006 Mayanglambam, 2011, Differential dephosphorylation of the protein kinase C‐zeta (PKCzeta) in an integrin alphaIIbbeta3‐dependent manner in platelets, Biochem Pharmacol, 82, 505, 10.1016/j.bcp.2011.05.022 Pradhan, 2010, Cross‐talk between serine/threonine protein phosphatase 2A and protein tyrosine phosphatase 1B regulates Src activation and adhesion of integrin alphaIIbbeta3 to fibrinogen, J Biol Chem, 285, 29059, 10.1074/jbc.M109.085167 Gushiken, 2008, Protein phosphatase 2A negatively regulates integrin alpha(IIb)beta(3) signaling, J Biol Chem, 283, 12862, 10.1074/jbc.M708804200 Molino, 1997, Thrombin receptors on human platelets. Initial localization and subsequent redistribution during platelet activation, J Biol Chem, 272, 6011, 10.1074/jbc.272.9.6011 Lordkipanidze, 2014, Characterization of multiple platelet activation pathways in patients with bleeding as a high‐throughput screening option: use of 96‐well Optimul assay, Blood, 123, e11, 10.1182/blood-2013-08-520387 de Witt, 2014, Identification of platelet function defects by multi‐parameter assessment of thrombus formation, Nat Commun, 5, 4257, 10.1038/ncomms5257 Welsh, 2014, A systems approach to hemostasis: 1. The interdependence of thrombus architecture and agonist movements in the gaps between platelets, Blood, 124, 1808, 10.1182/blood-2014-01-550335 Stalker, 2014, A systems approach to hemostasis: 3. Thrombus consolidation regulates intrathrombus solute transport and local thrombin activity, Blood, 124, 1824, 10.1182/blood-2014-01-550319 Tomaiuolo, 2014, A systems approach to hemostasis: 2. Computational analysis of molecular transport in the thrombus microenvironment, Blood, 124, 1816, 10.1182/blood-2014-01-550343 Sveshnikova, 2015, Compartmentalized calcium signaling triggers subpopulation formation upon platelet activation through PAR1, Mol BioSyst, 11, 1052, 10.1039/C4MB00667D Dolan, 2014, Systems modeling of Ca(2+) homeostasis and mobilization in platelets mediated by IP3 and store‐operated Ca(2+) entry, Biophys J, 106, 2049, 10.1016/j.bpj.2014.03.028